Poll
Article
Pharma Commerce's 2025 State of the Industry Survey
Author(s):
Key Takeaways
- The survey highlights evolving trends and strategies in the pharma sector, focusing on supply chain demands and go-to-market strategies.
- Data was collected from over 50 participants, with the largest group being consultants and vendor/partner organizations.
Capturing insights from executives and industry experts on the biggest challenges shaping pharma today, from drug pricing pressures and access barriers to supply chain shifts, digital adoption, and evolving patient-centered care strategies.
Pharmaceutical Commerce recently conducted a comprehensive survey on the evolving trends and strategies within the pharma sector, capturing insight from fellow executives, directors, and industry experts.
In this special slideshow presentation, we highlight the key data takeaways that surfaced from the findings—which focused on everything from supply chain demands to new go-to-market strategies.
The sampling of perspectives spotlights the key priorities for life sciences leaders and decision-makers at the moment and into the future. Data was gathered during the period of July 1 through Aug. 31, 2025, and reflects responses from more than 50 participants.
Leaders from consultants and vendor/partner organizations comprised the largest responder segment, at 32.14%. They were followed by those in supply chain operations and manufacturing; market access and patient support; the pharma C-suite; the biotech C-suite; commercial and marketing; regulatory and global affairs; and IT and data analytics.
Note: This survey was conducted amid developing most-favored nation (MFN) pricing and pending tariffs.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
